1. Home
  2. Buyout

Category: rare disease

Rare disease pharmacy specialist PANTHERx bought by private equity consortium

Nautic Partners, The Vistria Group and General Atlantic have agreed to buy rare pharmacy care specialist PANTHERx Rare from Centene Corporation. The post Rare disease pharmacy specialist PANTHERx bought by private equity consortium first appeared on

Booming rare disease drugmaker SOBI valued at $8bn through Advent, GIC buyout offer

Advent International and Singapore sovereign investor GIC have offered to buy booming rare-disease drugmaker Swedish Orphan Biovitrum in a deal valuing the business at about $8bn. The post Booming rare disease drugmaker SOBI valued at

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.